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When taking care of our patients and families in daily
clinical practice, it is difﬁcult to not solely be directed at
acute, short-term improvements. Typically, patients are
being referred to our clinical services at a time when
symptoms of mental disorders have already led to signiﬁ-
cant impairments on important areas such as social, aca-
demic, and family functioning. Then, obviously, we try to
put effective interventions in place that aim to decrease
symptoms as well as reduce impairments. Indeed, we now
have several treatments in the ﬁeld of child and adolescent
psychiatry with a solid evidence base [1]. Well-researched
examples include the use of stimulant medications for
attention-deﬁcit/hyperactivity disorder (ADHD), risperi-
done [2] and aripiprazole [3] for irritability in autism
spectrum disorders, and behavioral parent training [4] for
children with disruptive behavior problems.
Ideally, however, in addition to addressing the acute
needs of our pediatric patients, our interventions should be
truly aimed at preparing our children for a better life in the
long run. Will the interventions we apply contribute to the
better functioning of our patients as adults? The long-term
results of the Multimodal Treatment study of ADHD
(MTA) [5] have been complex, but clearly demonstrate that
there is not a simple relationship between impressive acute
treatment effects of well-monitored stimulant medication
and effects over the long run. Fortunately, the Treatment
for Adolescents with Depression Study (TADS) [6] that
investigated the effectiveness of ﬂuoxetine, cognitive-
behavioral therapy, and their combination in adolescents
with major depressive disorder was able to demonstrate
persistent beneﬁts of treatments over 1 year of naturalistic
follow-up.
This issue of European Child and Adolescent Psychiatry
contains several articles that deal with the long-time per-
spective in our ﬁeld. Gevensleben et al. [7] report on the
long-term follow-up of their randomised controlled trial of
neurofeedback versus a control treatment (a computerized
attention skills training) in children with ADHD and
demonstrated that behavioral improvements through neu-
rofeedback were actually maintained at a 6-month follow-
up. Longitudinal cohort studies are a classic way to
investigate the long-term effects of important environ-
mental factors for children’s development. Elberling et al.
[8] longitudinally studied the inﬂuence of perinatal and
socioeconomic data, and data on child mental illness
diagnosed in preschool years on psychosocial function at
5–7-year follow-up, in the Copenhagen Child Cohort,
which involves more than 6,000 children. Several markers
of socioeconomic disadvantages were found to be associ-
ated with mental health problems at 5–7 years of age. In
another large-scale longitudinal cohort study in Norway in
this issue, Lien et al. [9] showed that internalizing mental
health problems among adolescent girls were signiﬁcantly
associated with atopic conditions 3 years earlier, thus
demonstrating that atopy may have long-lasting effects on
mood and anxiety levels.
Finally, a truly long-term perspective on our ﬁeld is
provided by a wonderful overview by the most eminent
long-term leader and pioneer of child and adolescent psy-
chiatry. Professor Sir Michael Rutter gives a unique per-
spective on the developments from the mid-twentieth
century onwards, ending with a look ahead to the most
important opportunities and challenges as well as the
hazards that need to be avoided.
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